🩺 Service Update | Dr. Chetan Kalal
Modern liver care is no longer limited to treating advanced cirrhosis.
Our hepatology services are increasingly focused on:
✔ Fatty liver disease (MASLD/MASH)
✔ Liver fibrosis risk assessment
✔ FibroScan-based evaluation
✔ Obesity-related liver disease
✔ Metabolic hepatology
✔ Advanced cirrhosis management
✔ Liver transplant hepatology
With rising obesity, diabetes, and metabolic dysfunction in Indian patients, early identification of fibrosis has become critically important.
Because in fatty liver disease:
👉 Fat alone is common.
👉 Fibrosis determines outcomes.
Our approach emphasizes:
• Evidence-based hepatology
• Individualized metabolic assessment
• Early intervention strategies
• Long-term liver protection
“Treat phenotype, not just ultrasound.”
— Dr. Chetan Kalal
#Hepatology #FattyLiver #MASLD #MASH #LiverHealth #Fibrosis #FibroScan #MetabolicHepatology #Cirrhosis #ObesityMedicine
